“Without holding anything back, we shared our prevention, control and treatment experience,” she told reporters at a regular press briefing.
But over the course of the pandemic, the WHO repeatedly criticised Chinese authorities for their lack of transparency and cooperation.
A team of specialists led by the WHO and accompanied by Chinese colleagues investigated the pandemic’s origins in early 2021.
In a joint report, they favoured the hypothesis that the virus had been transmitted by an intermediary animal from a bat to a human, possibly at a market.
A team has not been able to return to China since, and WHO officials have repeatedly asked for additional data.
Mao said on Tuesday that “more and more clues” pointed “to Covid-19’s origins having a global scope”.
China was “willing to continue working with various parties to promote global scientific origin tracing and to make active efforts to prevent potential infectious diseases in the future”, she said.
Pandemic preparedness
This month, WHO director-general Tedros Adhanom Ghebreyesus said “the world would still face some of the same weaknesses and vulnerabilities that gave Covid-19 a foothold five years ago”, if a new pandemic emerged today.
“But the world has also learned many of the painful lessons the pandemic taught us, and has taken significant steps to strengthen its defences against future epidemics and pandemics,” he said.
In December 2021, spooked by the devastation caused by Covid, countries decided to start drafting an accord on pandemic prevention, preparedness and response.
The WHO’s 194 member states negotiating the treaty have agreed on most of what it should include, but are stuck on the practicalities.
A key fault line lies between Western nations with major pharmaceutical industry sectors and poorer countries wary of being sidelined when the next pandemic strikes.
While the outstanding issues are few, they include the heart of the agreement: the obligation to quickly share emerging pathogens, and then the pandemic-fighting benefits derived from them such as vaccines.
The deadline for the negotiations is May 2025.
- Agence France-Presse